ArticleThe oncologist2020

Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.

Tanja Cufer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.